modafinil has been researched along with Hallucination of Body Sensation in 10 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Withdrawal of the narcolepsy treatment and initiation of haloperidol 1 mg/day (the only antipsychotic treatment she could tolerate) improved the delusions, hallucinations and dysphoria but worsened the narcolepsy symptoms." | 3.85 | Narcolepsy-cataplexy and psychosis: a case study. ( Arango-Lopez, C; Canellas-Dols, F; Delgado, C; Peraita-Adrados, R, 2017) |
| "Past modafinil use was reported by 2." | 2.74 | Modafinil and zolpidem use by emergency medicine residents. ( Ankel, FK; Asplin, BR; Flottemesch, TJ; Ling, LJ; Mason, EJ; McBeth, BD; McNamara, RM, 2009) |
| "Narcolepsy is a serious neurological condition in which patients are overcome by persistent, excessive feelings of fatigue and drowsiness." | 2.45 | Narcolepsy: clinical decision making for the primary care physician. ( Hazin, R; Iqbal, M; Khan, F, 2009) |
| "Narcolepsy is a disabling disease with a prevalence of 0." | 2.44 | Pediatric narcolepsy. ( Husain, AM; Peterson, PC, 2008) |
| "Excessive daytime somnolence is a prevalent problem in medical practice and in society." | 2.43 | Conditions of primary excessive daytime sleepiness. ( Black, JE; Brooks, SN; Nishino, S, 2005) |
| "Narcolepsy is characterized by symptoms that include excessive sleepiness during the daytime, cataplexy, hypnagogic hallucinations and sleep paralysis." | 1.35 | Narcolepsy and psychotic states--a case report. ( Daliahu, Y; Melamed, Y; Paleacu, D, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canellas-Dols, F | 1 |
| Delgado, C | 1 |
| Arango-Lopez, C | 1 |
| Peraita-Adrados, R | 1 |
| Yasui-Furukori, N | 1 |
| Kusunoki, M | 1 |
| Kaneko, S | 1 |
| Melamed, Y | 1 |
| Daliahu, Y | 1 |
| Paleacu, D | 1 |
| Khan, F | 1 |
| Hazin, R | 1 |
| Iqbal, M | 1 |
| McBeth, BD | 1 |
| McNamara, RM | 1 |
| Ankel, FK | 1 |
| Mason, EJ | 1 |
| Ling, LJ | 1 |
| Flottemesch, TJ | 1 |
| Asplin, BR | 1 |
| Hsieh, CF | 1 |
| Lai, CL | 1 |
| Lan, SH | 1 |
| Liu, CK | 1 |
| Hsu, CY | 1 |
| Black, JE | 1 |
| Brooks, SN | 1 |
| Nishino, S | 1 |
| Plazzi, G | 1 |
| Parmeggiani, A | 1 |
| Mignot, E | 1 |
| Lin, L | 1 |
| Scano, MC | 1 |
| Posar, A | 1 |
| Bernardi, F | 1 |
| Lodi, R | 1 |
| Tonon, C | 1 |
| Barbiroli, B | 1 |
| Montagna, P | 1 |
| Cicognani, A | 1 |
| Oulis, P | 1 |
| Kouzoupis, AV | 1 |
| Kontoangelos, K | 1 |
| Pachou, E | 1 |
| Masdrakis, VG | 1 |
| Soldatos, CR | 1 |
| Peterson, PC | 1 |
| Husain, AM | 1 |
3 reviews available for modafinil and Hallucination of Body Sensation
| Article | Year |
|---|---|
Narcolepsy: clinical decision making for the primary care physician.
Topics: Benzhydryl Compounds; Biomarkers; Cataplexy; Central Nervous System Stimulants; Decision Making; Dia | 2009 |
Conditions of primary excessive daytime sleepiness.
Topics: Automobile Driving; Benzhydryl Compounds; Central Nervous System; Central Nervous System Stimulants; | 2005 |
Pediatric narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Child; Dextroamphetamine; Ghreli | 2008 |
1 trial available for modafinil and Hallucination of Body Sensation
| Article | Year |
|---|---|
Modafinil and zolpidem use by emergency medicine residents.
Topics: Adult; Akathisia, Drug-Induced; Amnesia; Anorexia; Benzhydryl Compounds; Central Nervous System Stim | 2009 |
6 other studies available for modafinil and Hallucination of Body Sensation
| Article | Year |
|---|---|
Narcolepsy-cataplexy and psychosis: a case study.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compound | 2017 |
Hallucinations associated with modafinil treatment for narcolepsy.
Topics: Adaptation, Psychological; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Drug Admi | 2009 |
Narcolepsy and psychotic states--a case report.
Topics: Antipsychotic Agents; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Comorbidit | 2009 |
Modafinil-associated vivid visual hallucination in a patient with Kleine-Levin syndrome: case report.
Topics: Adolescent; Benzhydryl Compounds; Female; Hallucinations; Humans; Kleine-Levin Syndrome; Modafinil | 2010 |
Narcolepsy-cataplexy associated with precocious puberty.
Topics: Aspartic Acid; Benzhydryl Compounds; Cataplexy; Child; Creatine; Cyclohexanols; Disorders of Excessi | 2006 |
Visual and coenesthetic hallucinations associated with modafinil.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Hallucinations; | 2008 |